Physiological assessment of myocardial perfusion using nuclear cardiology would enhance coronary artery disease patient care: Which imaging modality is best for evaluation of myocardial ischemia? (SPECT-side)

Circulation Journal

Volumn 75, Issue 3, 2011, Pages 713-723

  Yoshinaga, Keiichiro ^a   Manabe, Osamu ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood flow; Myocardial ischemia; Prognosis; Tomography

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; DIPYRIDAMOLE; DOBUTAMINE; FLUORINE 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; OXYGEN 15; RUBIDIUM 82; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201; VASODILATOR AGENT;

ARTICLE; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; EXERCISE TEST; GAMMA RADIATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MEDICINE; PATIENT CARE; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION EXPOSURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; RADIONUCLIDE IMAGING; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STRESS, PHYSIOLOGICAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79952334226     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1290     Document Type: Article

References (41)

1. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000; 101: 1465-1478.
2. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639-647.
3. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998; 32: 57-62.
4. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion spect in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
5. deKemp RA, Yoshinaga K, Beanlands RS. Will 3-dimensional pet-ct enable the routine quantification of myocardial blood flow? J Nucl Cardiol 2007; 14: 380-397.
6. Thompson RC, Cullom SJ. Issues regarding radiation dosage of cardiac nuclear and radiography procedures. J Nucl Cardiol 2006; 13: 19-23.
7. Yoshinaga K, Tamaki N, Ruddy T, DeKemp RA, Beanlands R. Evaluation of myocardial perfusion. In: Wahl R, editor. Principles and practice of PET and PET/CT. 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2009; 541-564.
8. Klocke FJBM, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, DeMaria AN, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidlines for the clinical use of radionuclide imaging). 2003. CardioSource: American College of Cardiology. http://www.cardiosource.org (accessed July 31, 2006).
9. Yoshinaga K, Chow BJ, dekemp RA, Thorn S, Ruddy TD, Davies RA, et al. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des 2005; 11: 903-932.
10. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without pci for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
11. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003; 107: 2900-2907.
12. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-1291.
13. Katritsis DG, Meier B. Percutaneous coronary intervention for stable coronary artery disease. J Am Coll Cardiol 2008; 52: 889-893.
14. Strauss HW, Harrison K, Langan JK, Lebowitz E, Pitt B. Thallium-201 for myocardial imaging: Relation of thallium-201 to regional myocardial perfusion. Circulation 1975; 51: 641-645.
15. Updated imaging guidelines for nuclear cardiology procedures, part 1. J Nucl Cardiol 2001; 8: G5-G58.
16. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of tl-201 and tc-99m sestamibi spect imaging (perfusion and ECG-gated spect) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29: 69-77.
17. Imaging guidelines for nuclear cardiology procedures, part 2. American Society of Nuclear Cardiology. J Nucl Cardiol 1999; 6: G47-G84.
18. Berman DS. Introduction: Technetium-99m myocardial perfusion imaging agents and their relation to thallium-201. Am J Cardiol 1990; 66: 1E-4E.
19. Schuijf JD, Poldermans D, Shaw LJ, Jukema JW, Lamb HJ, de Roos A, et al. Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2006; 33: 93-104.
20. Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Am Heart J 2001; 142: 934-944.
21. O'Keefe JH Jr, Barnhart CS, Bateman TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995; 75: 25D-34D.
22. Yoshinaga K, Chow BJ, Williams K, Chen L, deKemp RA, Garrard L, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006; 48: 1029-1039.
23. Matsuo S, Nakajima K, Yamasaki Y, Kashiwagi A, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese asymptomatic patients with type 2 diabetes: A study based on the J-ACCESS-2 database. Circ J 2010; 74: 1916-1921.
24. Usui Y, Chikamori T, Nakajima K, Hida S, Yamashina A, Nishimura T. Prognostic value of post-ischemic stunning as assessed by gated myocardial perfusion single-photon emission computed tomography: A subanalysis of the j-access study. Circ J 2010; 74: 1591-1599.
25. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984; 310: 819-824.
26. Miller DD, Donohue TJ, Younis LT, Bach RG, Aguirre FV, Wittry MD, et al. Correlation of pharmacological 99mtc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994; 89: 2150-2160.
27. Brown KA, Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 1993; 71: 865-867.
28. Matsumoto N, Nagao K, Hirayama A, Sato Y. Non-invasive assessment and clinical strategy of stable coronary artery disease by magnetic resonance imaging, multislice computed tomography and myocardial perfusion spect. Circ J 2010; 74: 34-40.
29. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008; 117: 103-114.
30. Yoshinaga K, Tamaki N. Imaging myocardial metabolism. Curr Opin Biotechnol 2007; 18: 52-59.
31. Beanlands RS, Chow BJ, Dick A, Friedrich MG, Gulenchyn KY, Kiess M, et al. CCS/CAR/CANM/CNCS/CANSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease: Executive summary. Can J Cardiol 2007; 23: 107-119.
32. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: Diagnosis and patient outcomes. Curr Probl Cardiol 2007; 32: 375-410.
33. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007; 50: 2002-2012.
34. US Department of Health and Human Services. FDA. Whole body scanning using computed tomography (CT). What are the risks from CT? http://www.fda.gov/cdrh/ct/risks.html#dose (accessed September 15, 2005).
35. Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, et al. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med 2009; 50: 635-643.
36. Yoshinaga K, Klein R, Tamaki N. Generator-produced rubidium-82 positron emission tomography myocardial perfusion imaging-from basic aspects to clinical applications. J Cardiol 2010; 55: 163-173.
37. Lertsburapa K, Ahlberg AW, Bateman TM, Katten D, Volker L, Cullom SJ, et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 2008; 15: 745-753.
38. Yoshinaga K, Manabe O, Katoh C, Chen L, Klein R, Naya M, et al. Quantitative analysis of coronary endothelial function with generator-produced 82rb PET: Comparison with 15o-labelled water PET. Eur J Nucl Med Mol Imaging 2010; 37: 2233-2241.
39. Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with Ecg-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006; 13: 24-33.
40. Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 2007; 49: 1052-1058.
41. Cheung SCW, Chan CWS. Cardiac magnetic resonance imaging: Choice of the year: Which imaging modality is best for evaluation of myocardial ischemia? (MRI-Side) Circ J 2011; 75: 724-731.